We would love to hear your thoughts about our site and services, please take our survey here.
6000 People done the virtual Escape Rooms x say £20.00/nr = £120,000.00??
Hi all. Looks like there’s some delayed sells popped up after hours from yesterday. Does anybody know when the seller could be finished? Are they selling all their shares or only part of them? Thank you.
Believe it's the 23rd December. Quite a few could be caught out here as they got their dates wrong. Even if FDA priority review isn't achieved then believe it's already priced in now from a high of low 80s. It was always a nice to have and has no baring on FDA approval although for some people on AIM an extra 4 months to wait is a long time.
Cathal also confirmed a cash dividend will be paid out to shareholders in 2021 using all the surplus cash in the bank they will have.
Somebody is embarrassing themselves now............... You’ve sold out, move on. Most rational people would wait until next week to wait until further news has been announced. Far to emotionally involved for my liking and has a temper to boot. Filtered.
It’s believed the environmental permit isn’t needed for the first lake but is required to support full nameplate capacity over full project life, I.e is needed for working on more than 1 lake. It sounds as if the company need to do a further raise (hopefully a small one) to enable the drawdown loan requirements to be met. If this is the case then this has all meant just a small dilution of share issue. Looks like more news to come next week.
Has anybody else noticed quite a lot of big buys today so far? There has been a few big sells but the big buys definitely out way them. Somebody has got confidence in loading up at this level.
I’m in agreement with you Brooko19. I to have assumed at this stage that something unexpected has happened and that will mean a small fundraise to cover the short term gap. We could be wrong but until I see anything to change this opinion then believe this is the likely scenario we find ourselves in. Tony has big skin in the game and is a genuine person but I do think this has come from left field and was something out of his control. I’m sure we will find out next week if we are right.
I wasn’t a shareholder but on one of his podcasts Justin advised he sold C4X at a loss (20% from memory). I always look out for Justin’s stocks and then make my own decision whether I buy and if I do when I sell. I bought ORPH at 6p and haven’t sold a single share and now it’s at 25p. Justin sold ORPH ages ago at a small profit but has said a few times since that he made a mistake and how much he likes Cathal Friel the Executive Chairman who has 50% of his net worth (£2 million) tied up in the company. I suppose Justin buying in beforehand and then bringing it to peoples attention, which makes the share price increase is his reward for doing the research but then some do drop back so it’s swings and roundabouts.
The source is somebody who is a fellow shareholder and who also does daily podcasts. They spoke to Tony and what I posted below is Tony’s word for word response.
Currently EPA approvals are not part of conditions for drawdown as no further approvals are required for commissioning and ramp up of plant/supply chain to nameplate capacity. Final approval is required to build extra ponds/tranches/bores to support full nameplate capacity over full project life. This was part of the unique "staged structure" of this project schedule. We (as in the company) are in the middle of finalising last CPs, the time consuming ones.
Completely agree that we got cross infected as a COVID play. POLX will be one of the companies to prosper even more due COVID-19 and long COVID.
Before COVID-19 I estimated that the company could be sold for £450 million within 2 years of FDA approval but the tech will be more valuable and be in more demand now due to long COVID. I'm now estimating it could now be sold for £500 million although if and when it's sold to Bracco Imaging then the value will be in relation to how quick it is sold. The longer POLX board can keep going without a sale then you would assume the more will be paid for it.
It looks as if Boris mentioning yesterday how important x ray machines will be for scanning lungs due to COVID-19 has given our share price a boost (not that it needed one). Only around a month to go worse case until we hear whether we qualify for priority FDA approval although wouldn't surprise me if they reply advising we qualify for fast track approval.
IMHO will land sometime within the next 8 weeks. Cathal doesn't want the share price to spike therefore the deal with Amazon or Apple or perhaps all the interested wearable parties will land without notice. You will have to be in it to win it. He advised the deal could be bigger than our market cap therefore anybody buying in now will automatically be on a free roll.
Yes 50p by the end of next year is my conservative aim but wouldn't be surprised if it's more like 60p not including any dividends.
Anybody who has done their research and listened to Cathal on his presentation evenings will know that even when a vaccine is available ORPH/HVIVO will still have a lot of COVID-19 challenge study model Contracts to come. It's believed ORPH/HVIVO will have 7 of these Contracts plus Cathal has also advised that big pharma's have told him they want to reserve slots in the future to test COVID-19 vaccines against each other.
As a long term holder, my share price target is for it to be 50p by end of next year (actually believe it could reach 60p) and this doesn't include potentially 3 dividends (Imutex sale, wearables deal and dividend from surplus cash sitting in the bank, which believe could happen mid to end of next year).
Ignore the noise/derampers and stick to your own research!!
First bought at 6p and now have an average of 7.26p. I haven't sold a single share and it's not crossed my mind to. Cut your losers and let your winners role. Taking 10%-20% gain will give you a good income but playing the long game and making 500%-1,000% will create wealth.
Somebody asking about a fundraise by a person who comes up with this message on my screen, "this message has been filtered, adjust your filters to view" just says it all. Anybody who has researched the company will know they've already made the market aware that a final fundraise will be needed once FDA approval is gained. With the share price going up by 50% very quickly it is mostly because big funds are increasing their position in the company and with most shares being in sticky hands then any kind of block buying will increase the share price. They obviously believe the share price is still cheap and will be below the fundraise price, which will be higher than the current share price as the company will do it once FDA approval is received. I also believe the fundraise will be for institutions and funds only or worse case only a small amount the retail investors, which will mean most new shares are in sticky hands. Anybody waiting for the fundraise before buying will only end up paying at a greater share price IMO.
There maybe a slight pull back, which you would expect but shares are so tightly held in this company and the herd/traders aren't involved in the company (yet) hence this board being very quiet so not expecting huge share price swings. It's nice to see the company finally being discovered by more retail investors. Best wishes all to all other shareholders...............